Akynzeo (Netupitant and Palonosetron) and Renal impairment
Result of checking the interaction of drug Akynzeo (Netupitant and Palonosetron) and disease Renal impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Population pharmacokinetic analysis showed that mild and moderate renal impairment (creatinine clearance 30 to 60 mL/min) did not significantly affect the pharmacokinetics of netupitant. The pharmacokinetics and safety of netupitant have not been studied in patients with severe renal impairment. Avoid use in patients with severe renal impairment or end-stage renal disease.
Generic Name: netupitant / palonosetron
Brand Name: Akynzeo
Synonyms: Akynzeo